Company Filing History:
Years Active: 2010
Title: Innovations in Therapeutic Vaccination by Peter Birk
Introduction
Peter Birk is an accomplished inventor based in Frederiksberg, Denmark. He has made significant contributions to the field of immunotherapy, particularly in the development of methods for therapeutic vaccination. His innovative approach focuses on inducing cell-mediated immunity against cellular antigens, which has the potential to revolutionize cancer treatment.
Latest Patents
Peter Birk holds a patent for "Methods for therapeutic vaccination." This invention discloses a method for inducing cell-mediated immunity against weak antigens, notably self-proteins. The method involves antigen presenting cells that present at least one cytotoxic T-lymphocyte (CTL) epitope of the weak antigen while simultaneously presenting at least one foreign T-helper lymphocyte epitope. In preferred embodiments, the antigen is a cancer-specific antigen, such as PSM, Her2, or FGF8b. The method can be implemented using traditional polypeptide vaccination, live attenuated vaccines, or nucleic acid vaccination. Additionally, the invention provides immunogenic analogues of PSM, Her2, and FGF8b, as well as nucleic acid molecules encoding these analogues. Vectors and transformed cells are also disclosed, along with a method for identifying immunogenic analogues of weak or non-immunogenic antigens. Peter Birk has 1 patent to his name.
Career Highlights
Peter Birk is associated with Bn Immunotherapeutics, Inc., where he continues to advance his research in therapeutic vaccination. His work is pivotal in the ongoing efforts to enhance cancer immunotherapy and improve patient outcomes.
Collaborations
Peter collaborates with notable colleagues, including Lucilla Steinaa and Jesper Haaning, who contribute to the innovative research environment at Bn Immunotherapeutics, Inc.
Conclusion
Peter Birk's contributions to therapeutic vaccination represent a significant advancement in immunotherapy. His innovative methods have the potential to change the landscape of cancer treatment and improve the lives of many patients.